We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
+$29.7M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.83%
Holding
1,447
New
32
Increased
612
Reduced
360
Closed
43

Top Buys

Rank Stock Value
1
FR icon
First Industrial Realty Trust
FR
+$172M
2
REXR icon
Rexford Industrial Realty
REXR
+$156M
3
DLR icon
Digital Realty Trust
DLR
+$132M
4
WELL icon
Welltower
WELL
+$116M
5
CPT icon
Camden Property Trust
CPT
+$79.4M

Top Sells

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$243M
2
PLD icon
Prologis
PLD
+$168M
3
DOC icon
Healthpeak Properties
DOC
+$114M
4
EQIX icon
Equinix
EQIX
+$55.8M
5
EXR icon
Extra Space Storage
EXR
+$52.3M

Sector Composition

Rank Sector Weight
1 Real Estate 59.18%
2 Technology 9.44%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
1126
Supernus Pharmaceuticals
SUPN
$2.71B
$6K ﹤0.01%
182
– –
XNCR icon
1127
Xencor
XNCR
$1.48B
$6K ﹤0.01%
222
– –
TWOU
1128
DELISTED
2U Inc
TWOU
$6K ﹤0.01%
30
-30
-50% -$7.81K
AMPH icon
1129
Amphastar Pharmaceuticals
AMPH
$910M
$5K ﹤0.01%
165
– –
LGND icon
1130
Ligand Pharmaceuticals
LGND
$5.88B
$5K ﹤0.01%
101
– –
MYGN icon
1131
Myriad Genetics
MYGN
$491M
$5K ﹤0.01%
267
– –
NVAX icon
1132
Novavax
NVAX
$1.23B
$5K ﹤0.01%
291
– –
RVMD icon
1133
Revolution Medicines
RVMD
$39.2B
$5K ﹤0.01%
277
– –
SWTX
1134
DELISTED
SpringWorks Therapeutics
SWTX
$5K ﹤0.01%
184
– –
TVTX icon
1135
Travere Therapeutics
TVTX
$5.36B
$5K ﹤0.01%
208
– –
ZNTL icon
1136
Zentalis Pharmaceuticals
ZNTL
$337M
$5K ﹤0.01%
212
– –
KDNY
1137
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$5K ﹤0.01%
230
– –
ACRS icon
1138
Aclaris Therapeutics
ACRS
$728M
$4K ﹤0.01%
248
– –
ADPT icon
1139
Adaptive Biotechnologies
ADPT
$3.65B
$4K ﹤0.01%
530
– –
AKRO
1140
DELISTED
Akero Therapeutics
AKRO
$4K ﹤0.01%
119
– –
AUPH icon
1141
Aurinia Pharmaceuticals
AUPH
$1.96B
$4K ﹤0.01%
528
– –
CRNX icon
1142
Crinetics Pharmaceuticals
CRNX
$8.88B
$4K ﹤0.01%
199
– –
DAWN
1143
DELISTED
Day One Biopharmaceuticals
DAWN
$4K ﹤0.01%
181
– –
ENTA icon
1144
Enanta Pharmaceuticals
ENTA
$369M
$4K ﹤0.01%
69
– –
KYNB
1145
Kyntra Bio
KYNB
$27.9M
$4K ﹤0.01%
13
– –
GMAB icon
1146
Genmab
GMAB
$17.7B
$4K ﹤0.01%
137
– –
MDGL icon
1147
Madrigal Pharmaceuticals
MDGL
$12.7B
$4K ﹤0.01%
57
– –
PACB icon
1148
Pacific Biosciences
PACB
$447M
$4K ﹤0.01%
682
– –
PCVX icon
1149
Vaxcyte
PCVX
$7.69B
$4K ﹤0.01%
179
– –
RGNX icon
1150
Regenxbio
RGNX
$632M
$4K ﹤0.01%
146
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q3 2022 Portfolio in Review

As of Q3 2022, Daiwa Securities Group held 1,447 positions worth $12B, down 8% from $13.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q3 2022 filing shows 32 new, 612 increased, 360 reduced and 43 closed positions. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M. The largest sale was Duke Realty Corp., an estimated $243M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2022 buy was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M.
  • Daiwa Securities Group added most to First Industrial Realty Trust in Q3 2022, an estimated $172M increase.
  • Daiwa Securities Group's biggest Q3 2022 reduction was Duke Realty Corp., cutting an estimated $243M.
  • Daiwa Securities Group fully exited Chefs' Warehouse in Q3 2022, selling an estimated $2.69M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12B portfolio in Q3 2022.
  • Daiwa Securities Group opened 32 new positions and closed 43 in Q3 2022.
  • Daiwa Securities Group's portfolio value fell 8% quarter-over-quarter to $12B.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.